IGFBP2 and cancer: The MIIP protein has been previously demonstrated to bind to a product of an oncogene, IGFBP-2, which is commonly upregulated in the advanced stages of cancer, and to inhibit the migration- and invasion-enhancing functions of IGFBP-2 (6).